Skip to content
10-K

Annual Report

MapLight Therapeutics, Inc. MPLT

0001193125-26-125072

← back to feed
Filed
Mar 26, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 19, 2026 42.44M sh
Shares Diluted FY 2025 · Dec 31, 2025 8.68M sh
Shares Diluted FY 2025 · Dec 31, 2024 736.18K sh
Capex FY 2025 · Dec 31, 2025 $473K
Capex FY 2025 · Dec 31, 2024 $770K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$138.14M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$78.82M
Short Term Investments FY 2025 · Dec 31, 2025 $258.37M
Short Term Investments FY 2025 · Dec 31, 2024 $70.54M
Cash And Equivalents FY 2025 · Dec 31, 2025 $46.73M
Cash And Equivalents FY 2025 · Dec 31, 2024 $38.25M
Stockholders Equity FY 2025 · Dec 31, 2025 $458.37M
Stockholders Equity FY 2025 · Dec 31, 2024 −$193.63M
Stockholders Equity FY 2025 · Dec 31, 2023 −$117.59M
Current Liabilities FY 2025 · Dec 31, 2025 $16.23M
Current Liabilities FY 2025 · Dec 31, 2024 $15.92M
Total Liabilities FY 2025 · Dec 31, 2025 $21.14M
Total Liabilities FY 2025 · Dec 31, 2024 $21.72M
Current Assets FY 2025 · Dec 31, 2025 $324.67M
Current Assets FY 2025 · Dec 31, 2024 $114.6M
Total Assets FY 2025 · Dec 31, 2025 $479.51M
Total Assets FY 2025 · Dec 31, 2024 $136.92M
Eps Diluted FY 2025 · Dec 31, 2025 −$18.56
Eps Diluted FY 2025 · Dec 31, 2024 −$105.38
Eps Basic FY 2025 · Dec 31, 2025 −$18.56
Eps Basic FY 2025 · Dec 31, 2024 −$105.38
Sga Expense FY 2025 · Dec 31, 2025 $30.73M
Sga Expense FY 2025 · Dec 31, 2024 $14.42M
Rd Expense FY 2025 · Dec 31, 2025 $138.35M
Rd Expense FY 2025 · Dec 31, 2024 $68.52M
Net Income FY 2025 · Dec 31, 2025 −$161.15M
Net Income FY 2025 · Dec 31, 2024 −$77.58M
Operating Income FY 2025 · Dec 31, 2025 −$169.08M
Operating Income FY 2025 · Dec 31, 2024 −$82.95M